Earnings Summary

Horizon Therapeutics Public Ltd Co ’s revenue jumped 7.82% since last year same period to $944.96Mn in the Q2 2023. On a quarterly growth basis, Horizon Therapeutics Public Ltd Co  has generated 13.57% jump in its revenue since last 3-months.

Horizon Therapeutics Public Ltd Co ’s net profit jumped 108.4% since last year same period to $127.07Mn in the Q2 2023. On a quarterly growth basis, Horizon Therapeutics Public Ltd Co  has generated 132.37% jump in its net profits since last 3-months.

Horizon Therapeutics Public Ltd Co ’s net profit margin jumped 93.28% since last year same period to 13.45% in the Q2 2023. On a quarterly growth basis, Horizon Therapeutics Public Ltd Co  has generated 104.61% jump in its net profit margins since last 3-months.

Horizon Therapeutics Public Ltd Co ’s earning per share (EPS) estimates for the current quarter stand at 1.27 - a 0.79% jump from last quarter’s estimates.

Horizon Therapeutics Public Ltd Co ’s earning per share (EPS) estimates for the current year stand at 1.27.

Horizon Therapeutics Public Ltd Co ’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2023. This indicates that the Horizon Therapeutics Public Ltd Co  has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.